Symptom Clusters That Included Gastrointestinal Symptoms Among Children Receiving Cancer Treatments: A Scoping Review
18
Issued Date
2023-04-21
Resource Type
eISSN
15380688
Scopus ID
2-s2.0-85158106645
Pubmed ID
37155980
Journal Title
Oncology nursing forum
Volume
50
Issue
3
Start Page
381
End Page
395
Rights Holder(s)
SCOPUS
Bibliographic Citation
Oncology nursing forum Vol.50 No.3 (2023) , 381-395
Suggested Citation
Kamkhoad D., Santacroce S.J., Phonyiam R., Wang M. Symptom Clusters That Included Gastrointestinal Symptoms Among Children Receiving Cancer Treatments: A Scoping Review. Oncology nursing forum Vol.50 No.3 (2023) , 381-395. 395. doi:10.1188/23.ONF.381-395 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/81571
Title
Symptom Clusters That Included Gastrointestinal Symptoms Among Children Receiving Cancer Treatments: A Scoping Review
Author(s)
Author's Affiliation
Other Contributor(s)
Abstract
PROBLEM IDENTIFICATION: Composition and measurement of the gastrointestinal (GI) symptom cluster (SC) has been inconsistent; therefore, a gap exists in understanding of the GI SC. The purpose of this study was to synthesize findings from prior studies to better understand the GI SC and accompanying non-GI symptoms in children receiving cancer treatment. LITERATURE SEARCH: PubMed®, Embase®, CINAHL®, Scopus®, and PsycINFO® databases were searched through February 2022. Of 661 articles identified, 8 met inclusion criteria. DATA EVALUATION: A standardized investigator-developed form was used to extract data from eligible studies, including study and sample characteristics, analytic procedure, SCs that included GI symptoms, and influencing factors. SYNTHESIS: The 12 most frequently reported GI and accompanying non-GI symptoms were identified across 20 SCs. Phi correlation coefficients were calculated as indicators of strength of association between each pair of co-occurring symptoms within an SC. IMPLICATIONS FOR RESEARCH: Future studies should develop and test tools to comprehensively assess GI and accompanying non-GI symptoms and interventions that target shared underlying mechanisms.